Both experimental and clinical investigations have explored NRF2 modulation to mitigate liver damage, attenuate inflammation, and enhance hepatocyte viability.5,6 Consequently, identifying compounds capable of activating the NRF2 pathway holds potential for advancing liver disease management strategies. The gene discussed is NFE2L2; the disease is liver disorder.